QR-koodi

[18F]mFBG PET/CT surpasses [18F]FDG PET/CT for evaluation of pediatric neuroblastoma

Purpose[18F]FDG PET/CT serves as an alternative imaging modality for neuroblastoma in cases where [123I]MIBG yields negative results or is unavailable. [18F]mFBG, a novel PET tracer for neuroblastoma imaging, requires further clinical validation. This preliminary study aims to evaluate the efficacy...

Täydet tiedot

Tallennettuna:
Päätekijät: Wenqian Zhang, Chao Yang, Zhenzhen Zhao, Shunhao Zhou, Yanyao Han, Chenxi Zheng, Yalan Xiong, Changchun Li, Yao Zhang, Zhenni Wang, Liang Cai, Shan Wang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2025-09-01
Sarja:Frontiers in Oncology
Aiheet:
[18F]mFBG
[18F]FDG
norepinephrine transporter
neuroblastoma
PET/CT
Linkit:https://www.frontiersin.org/articles/10.3389/fonc.2025.1627403/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia